Table 5.

Summary of the diagnostic ability of EUS-FNA for differentiating extrahepatic cholangiocarcinoma from benign biliary disease.

Author (Year)	No. Cases	Sensitivity, %	Specificity, %	Accuracy, %	Adverse Event, %
Fritscher-Ravens (2004) [17]	44	89	100	91	0
Byrne (2004) [18]	35	63	100	83	0
Rösch (2004) [11]	11 a	25	100	NA	0
Lee (2004) [19]	28	47	100	NA	0
Eloubeidi (2006) [20]	25	86	100	88	0
DeWitt (2006) [21]	24	77	100	79	0
Meara (2006) [22]	43	87	100	91	0
Mohanmadnejad (2011) [23]	74	73	NA	NA	1, hemobilia
Ohshima (2011) [10]	22	100	100	100	0
Nayar (2012) [24]	32	60	100	74	0
Krishna (2012) [25]	28	67	100	79	0
Weilert (2014) [9]	15 a	79	NA	80	0
Téllez-Ávila (2014) [16]	39	79	100	82	0
Onda (2016) [12]	47	84	100	87	0
Our study	19	82	88	84	0

^a Patients with pancreatic cancer were excluded.